NEW HOME. NEW HOPE. DRUG REPOSITIONING Services.
Maximize return on R&D. Market your drug faster. Generate new income. Finding a new home for an existing drug that might have more potential, or a compound that didn't succeed the first time out, offers a lot of people new hope. And helps to grow your business. We can help you turn the potential into a reality.
Webinar: Knowledge-Based Drug Repositioning
Watch our webinar investigating how improved access to high quality data and world class analytical capabilities have driven companies' abilities to reposition existing assets into new diseases. We discuss how the business of drug repositioning has been transformed from an opportunistic approach to a scientifically robust and logical process for finding new uses for drugs in well defined and selected patient populations.
White Paper: Knowledge-Based Drug Repositioning To Drive R&D Productivity
Repositioned drugs have already proven to effectively address unmet medical needs. And they have the potential of having higher success rates and faster cycle times. Read all about it in our drug repositioning white paper, along with case studies of how Thomson Reuters can help you identify existing compounds with the potential to enhance your portfolio, and bring new hope to patients around the world.
THREE ROADS TO NEW SUCCESS
We help you evaluate repurposing opportunities by connecting data on drugs, disease pathways, and proteins in three ways: Drug Focus, Target Focus, Disease Focus.
- DRUG FOCUS - A structure similarity based method to find new indications that help exploit the full value of a drug.
- TARGET FOCUS - Pathway analysis and protein structure methods help find new therapeutic uses for the library of drugs that modulate a particular mechanistic target or pathway
- DISEASE FOCUS - Find new approaches to drug intervention in a disease or sub-population and identify available candidates.
A SCIENCE LEAD SERVICE, EXPERT TO EXPERT.
Our Professional Services team employs our proprietary content and analytical tools in harmony with your in-house data. The result? New uses for drugs in well defined and selected patient populations through scientifically robust and logical approaches.
Tel: +1 800.336.4474
Tel: +1 215.386.0100
Fax: +1 215.386.2911
Europe, Middle East & Africa
Tel: +44 20.7433.4000
Brazil: +55 11 8370 9845
Other Countries: +1 215 823 5674
Tel: +81 3.4589.3103
Tel: 0800 888.8855 (free dial from Japan only)
Fax: +81 3.4589.3240
Australia & New Zealand:
+61 2 8587 7636
China: +86 10 5760 1200
India: +91 11 3044 6419
Korea: +82 2 2076 8100
South East Asia & Pakistan:
+65 6775 5088
Taiwan: +886 2 2503 3034
LIFE SCIENCES PROFESSIONAL SERVICES
Our Professional Services team works with you to provide new disease understanding, therapeutic and business insights, and better decision-support systems. We combine expert analysts in use of our content and technology assets, proprietary analytical and visualization tools, and deep expertise in the pharmaceutical and life sciences business. Benefit from tailored solutions to meet your unique business needs for faster, more informed decisions with higher confidence.